UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 9
September-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2309553


Registration ID:
525454

Page Number

f454-f457

Share This Article


Jetir RMS

Title

A Review on: QbD Engineered Method Development and Validation of RP-HPLC for Simultaneous Estimation of Anti-Diabetic Agents.

Abstract

An isocratic reversed- phase high- performance liquid chromatography( RP- HPLC) system has been developed for rapid-fire and contemporaneous separation and estimation of 3 antidiabetic medicines, videlicet, metformin, pioglitazone, and glimepiride, in mortal tube within 3 min. A reversed- phase RP- HPLC system was developed for the contemporaneous determination of metformin hydrochloride( MET), pioglitazone( PIO), and glimepiride( GLM) in their combined lozenge forms and spiked mortal tube. Quality threat operation principles for determining the critical system parameters (CMPs) and fractional factorial design were made to screen CMPs and latterly, the Box – Behnken design was employed. Literature check reveals good number of logical styles for the estimation of TEN and MET collectively or in combination with other medicines using UV spectrophotometry6- 8, HPLC9- 19, HPTLC20 and LC- MS/ MS21. The proposed procedure was optimized by espousing a quality- by- design approach. The influence of different factors on chromatographic responses was optimized by applying the two- position full factorial design (25). The optimum chromatographic separation was achieved using Hypersil BDS C18 column at 45 °C, and the mobile phase pumped isocratically composed of methanol potassium dihydrogen phosphate buffer(6.6 mM; pH 7, 6733 v/ v) at an inflow rate of0.814 mL/ min using 235 nm as a discovery wavelength.

Key Words

RP-HPLC, metformin, pioglitazone, glimepiride, Quality by design, HPLC.

Cite This Article

"A Review on: QbD Engineered Method Development and Validation of RP-HPLC for Simultaneous Estimation of Anti-Diabetic Agents.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 9, page no.f454-f457, September-2023, Available :http://www.jetir.org/papers/JETIR2309553.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A Review on: QbD Engineered Method Development and Validation of RP-HPLC for Simultaneous Estimation of Anti-Diabetic Agents.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 9, page no. ppf454-f457, September-2023, Available at : http://www.jetir.org/papers/JETIR2309553.pdf

Publication Details

Published Paper ID: JETIR2309553
Registration ID: 525454
Published In: Volume 10 | Issue 9 | Year September-2023
DOI (Digital Object Identifier):
Page No: f454-f457
Country: Aurangabad, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00071

Print This Page

Current Call For Paper

Jetir RMS